Literature DB >> 15965214

Restless legs syndrome and low brain iron levels in patients with haemochromatosis.

J Haba-Rubio1, L Staner, C Petiau, G Erb, T Schunck, J P Macher.   

Abstract

Regional brain iron levels of two patients with haemochromatosis and severe restless legs syndrome (RLS) were assessed using R2' magnetic resonance imaging (MRI) sequences in both patients and in nine healthy controls. R2' relaxation rates in the patients were decreased in the substantia nigra, red nucleus, and pallidum when compared with the controls. These results indicate that local brain iron deficiency may occur in patients with haemochromatosis and suggest a role for brain iron metabolism in the pathophysiology of RLS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15965214      PMCID: PMC1739708          DOI: 10.1136/jnnp.2003.030536

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  15 in total

1.  Movement disorder due to aceruloplasminemia and incorrect diagnosis of hereditary hemochromatosis.

Authors:  Alfonso Fasano; Anna Rita Bentivoglio; Cesare Colosimo
Journal:  J Neurol       Date:  2007-02-14       Impact factor: 4.849

2.  Restless legs syndrome/Willis-Ekbom disease prevalence in beta thalassemia patients.

Authors:  Euthimia Dimitriadou; Christoforos D Giannaki; Maria Tsekoura; Ioannis Stefanidis; Georgios M Hadjigeorgiou; Eleftherios Lavdas; Christina Karatzaferi; Giorgos K Sakkas
Journal:  Sleep Breath       Date:  2017-04-19       Impact factor: 2.816

3.  Periodic limb movements and disrupted sleep in children with sickle cell disease.

Authors:  Valerie E Rogers; Carole L Marcus; Abbas F Jawad; Kim Smith-Whitley; Kwaku Ohene-Frempong; Cheryl Bowdre; Julian Allen; Raanan Arens; Thornton B A Mason
Journal:  Sleep       Date:  2011-07-01       Impact factor: 5.849

4.  Association of exposure to manganese and iron with relaxation rates R1 and R2*- magnetic resonance imaging results from the WELDOX II study.

Authors:  Beate Pesch; Ulrike Dydak; Anne Lotz; Swaantje Casjens; Clara Quetscher; Martin Lehnert; Jessica Abramowski; Christoph Stewig; Chien-Lin Yeh; Tobias Weiss; Christoph van Thriel; Lennard Herrmann; Siegfried Muhlack; Dirk Woitalla; Benjamin Glaubitz; Tobias Schmidt-Wilcke; Thomas Brüning
Journal:  Neurotoxicology       Date:  2017-08-25       Impact factor: 4.294

Review 5.  Animal models of RLS phenotypes.

Authors:  Richard P Allen; Nathan C Donelson; Byron C Jones; Yuqing Li; Mauro Manconi; David B Rye; Subhabrata Sanyal; Juliane Winkelmann
Journal:  Sleep Med       Date:  2016-09-02       Impact factor: 3.492

6.  Iron and restless legs syndrome: treatment, genetics and pathophysiology.

Authors:  James R Connor; Stephanie M Patton; Konrad Oexle; Richard P Allen
Journal:  Sleep Med       Date:  2016-11-10       Impact factor: 3.492

7.  Motor restlessness, sleep disturbances, thermal sensory alterations and elevated serum iron levels in Btbd9 mutant mice.

Authors:  Mark P DeAndrade; Russell L Johnson; Erica L Unger; Li Zhang; Thomas van Groen; Karen L Gamble; Yuqing Li
Journal:  Hum Mol Genet       Date:  2012-06-07       Impact factor: 6.150

8.  Restless legs syndrome and sleep quality among adult sickle cell disease patients.

Authors:  Siraj Omar Wali; Ibrahim AlQassas; Roah Merdad; Rajaa Alsaggaf; Fatin Al-Sayes
Journal:  Sleep Breath       Date:  2017-11-19       Impact factor: 2.816

9.  Association Between Periodic Limb Movements in Sleep and Cerebrovascular Changes in Children With Sickle Cell Disease.

Authors:  Jenny Lin; Kerry Morrone; Deepa Manwani; Rina Chernin; Ellen J Silver; Keivan Shifteh; Sanghun Sin; Raanan Arens; Katharina Graw-Panzer
Journal:  J Clin Sleep Med       Date:  2019-07-15       Impact factor: 4.062

Review 10.  Iron in Restless Legs Syndrome.

Authors:  Eva C Schulte; Maria Kaffe; Barbara Schormair; Juliane Winkelmann
Journal:  Mov Disord Clin Pract       Date:  2014-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.